- Oops!Something went wrong.Please try again later.
SALT LAKE CITY, UT, March 22, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original equipment manufacturer (OEM) of silicon nitride ceramic for medical and non-medical applications, announced today the filing of its 10-K for the year ended December 31, 2020.
2020 represented SINTX’s second full year as an advanced materials company. As COVID-19 spread and negatively impacted multiple potential opportunities, the Company was able to quickly and successfully adjust its 2020 strategic plan and capitalize on the discovery that its silicon nitride rapidly inactivates the SARS-CoV-2 virus. SINTX aggressively invested in key personnel, new collaborations with university and government laboratories, and new capital equipment. SINTX was able to engage with new partners and begin supporting their development of new antipathogenic products across a wide range of applications. SINTX is now leveraging the foundational successes of 2020 and is excited about its future. 2021 represents SINTX’s 25th year in business.
SINTX plans to host a conference call to provide an update on the business. The call is scheduled for Tuesday, March 30, 2021 at 1:30 p.m. ET. The call can be accessed through dial-in: Toll-free 877-524-8416; International 412-902-1028. For those who are not available to listen to the call, a digital replay will be archived on the News & Media section of the SINTX website under Presentations.
Questions will not be taken during the call. Investors and interested parties may submit questions prior to the call via email to IR@SINTX.com. Questions will be accepted through 9:00 a.m. ET, on Thursday, March 22, 2021.
About SINTX Technologies, Inc.
SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners. The Company presently manufactures silicon nitride powders and components in its FDA registered, ISO 9001:2015 certified, ISO 13485:2016 certified, and AS9100D certified manufacturing facility.
For more information on SINTX Technologies or its silicon nitride material platform, please visit www.sintx.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA) that are subject to a number of risks and uncertainties. Risks and uncertainties that may cause such differences include, among other things: incorporation of silicon nitride into personal protective equipment may not be safe or effective; volatility in the price of SINTX’s common stock; the uncertainties inherent in new product development, including the cost and time required to commercialize such product(s); market acceptance of our products once commercialized; SINTX’s ability to raise additional funding and other competitive developments. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations, and beliefs. There can be no assurance that any of the anticipated results will occur on a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 22, 2021, and in SINTX’s other filings with the SEC. SINTX disclaims any obligation to update any forward-looking statements. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.
Business Inquiries for SINTX:
Media Inquiries for SINTX:
Associate Director, Content and PR
The Summit Group